Enhanced Mitochondrial Calcium Uptake Suppresses Atrial Fibrillation Associated With Metabolic Syndrome.
atrial arrhythmias
calcium
diabetic cardiomyopathy
metabolism
Journal
Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365
Informations de publication
Date de publication:
06 12 2022
06 12 2022
Historique:
received:
05
06
2022
revised:
12
09
2022
accepted:
20
09
2022
entrez:
1
12
2022
pubmed:
2
12
2022
medline:
6
12
2022
Statut:
ppublish
Résumé
Patients with metabolic syndrome (MetS) have an increased risk of atrial fibrillation (AF). Impaired Ca The aim of this study was to determine the initial mechanisms related to AF susceptibility and mitochondrial dysfunction encountered in metabolic cardiomyopathy. A total of 161 mice and 34 patients were studied. Mitochondrial Ca Increased expression of the MICUs subunits of the MCUC (1.00 ± 0.33 AU vs 1.29 ± 0.23 AU; P = 0.034) was associated with impaired mitochondrial Ca Impaired MCUC activity and mitochondrial Ca
Sections du résumé
BACKGROUND
Patients with metabolic syndrome (MetS) have an increased risk of atrial fibrillation (AF). Impaired Ca
OBJECTIVES
The aim of this study was to determine the initial mechanisms related to AF susceptibility and mitochondrial dysfunction encountered in metabolic cardiomyopathy.
METHODS
A total of 161 mice and 34 patients were studied. Mitochondrial Ca
RESULTS
Increased expression of the MICUs subunits of the MCUC (1.00 ± 0.33 AU vs 1.29 ± 0.23 AU; P = 0.034) was associated with impaired mitochondrial Ca
CONCLUSIONS
Impaired MCUC activity and mitochondrial Ca
Identifiants
pubmed: 36456051
pii: S0735-1097(22)07040-1
doi: 10.1016/j.jacc.2022.09.041
pii:
doi:
Substances chimiques
Calcium
SY7Q814VUP
Anti-Arrhythmia Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2205-2219Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Funding Support and Author Disclosures Dr Fauconnier was supported by the Fondation de France (No. 00056858/ No. 00121055). Drs Fauconnier and Montaigne were supported by ANR CALMOS (ANR-18-CE17-0003). Dr Panel was supported by the Fondation Lefoulon-Delalande. Drs Dr Panel and Lacampagne were supported by the Fondation pour la Recherche Médicale (No. DPC20171138967). Drs Montaigne, Butruille, Woitrain, and Decoin are supported by grants from Agence Nationale pour la Recherche (ANR-10-LABX-0046, ANR TOMIS-Leukocyte: ANR-CE14-0003-01), the Leducq Foundation LEAN Network 16CVD01. and the National Center for Precision Diabetic Medicine–PreciDIAB (ANR-18-IBHU-0001;20001891/NP0025517; 2019_ESR_11). All authors have reported that they have no relationships relevant to the contents of this paper to disclose.